Synergistic ADPR Combinations for Enhanced Therapeutic Efficacy

The present inventive concept integrates 5′-adenosine diphosphate ribose (ADPR) with distinct technologies like AI, IoT, blockchain, and nanomaterials to create novel systems and methods for treating adenovirus-related diseases, eye disorders, cancer, and injuries.

The original patent disclosed the use of ADPR for treating various diseases, but its efficacy was limited by the lack of personalized treatment planning, inefficient tracking, and inadequate monitoring. The present inventive concept addresses these limitations by combining ADPR with advanced technologies to enhance therapeutic efficacy and patient outcomes.

The inventive concept comprises systems and methods that integrate ADPR with AI-powered diagnostic systems for personalized treatment planning, blockchain-based tracking modules for monitoring administration and efficacy, IoT-enabled sensors for real-time monitoring of treatment efficacy, and nanomaterial-based delivery systems for targeted release of ADPR. These synergistic combinations enable more effective treatment of adenovirus-related diseases, eye disorders, cancer, and injuries.

The present inventive concept's novelty lies in the unexpected integration of ADPR with advanced technologies, resulting in a more effective and efficient treatment approach. The inventive step is the recognition that these synergistic combinations can overcome the limitations of the original patent and provide better therapeutic outcomes.

Alternative embodiments of the inventive concept may include the use of other nucleotides, different AI algorithms, or various nanomaterials. Variations may involve the integration of ADPR with other technologies, such as robotics or virtual reality, to further enhance therapeutic efficacy.

The present inventive concept has significant commercial potential in the pharmaceutical and healthcare industries, particularly in the areas of infectious diseases, ophthalmology, oncology, and wound care. The target market includes pharmaceutical companies, hospitals, and research institutions seeking to develop more effective treatment approaches.